22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States
- Pinnacle VLN ® from 22nd Century Gains 2 nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution.
- 08/04/2025
|
22nd Century Applauds the American Academy of Family Physicians Comments and Support of the FDA's Proposed Reduced Nicotine Mandate to Reduce Smoking, Transform Public Health, Save Lives and Reduce Health Costs
- 22nd Century VLN ® products are the only combustible cigarettes authorized by the FDA as a reduced nicotine content product that comply with the FDA proposed rule MOCKSVILLE, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today commented on responses provided to the U.S. Food and Drug Administration to date as part of its open comment period on the proposed new Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products.
- 07/29/2025
|
22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products
- State Authorizations Mean Even More Adult Smokers Will Be Able to Purchase VLN ® , Partner VLN ® , Smoker Friendly and Pinnacle Products
- 07/17/2025
|
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate
- Multiple Tobacco Brands Partnering with 22nd Century to Expand Availability and Awareness of VLN Based Reduced Nicotine Content Products
- 07/16/2025
|
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less
- Extensive Clinical Data Continues to Demonstrate VLN ® Reduced Nicotine Content Tobacco Helps Reduce Smoking and Increase Quit Attempts Growing List of VLN ® Based Cigarette Brands Bring Non-Addictive Alternatives to the Fight Against Smoking MOCKSVILLE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction today announces a corporate update regarding its Modified Risk Tobacco Product renewal process for its innovative VLN® reduced nicotine content products - the first and only combustible cigarette authorized by the U.S. Food and Drug Administration specifically to reduce the health harms of smoking.
- 07/10/2025
|
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption
- 100mm Cigarettes Comprise Approximately Half the U.S. Market, Giving Even More Smokers a Familiar Choice as They Seek Ways to Change Their Smoking Behavior First FDA Submission Planned for Q4 2025 MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced the advancement of a 100mm VLN® reduced nicotine content cigarette.
- 06/26/2025
|
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain
- Launching New Pinnacle VLN and Moist Snuff Products in More Than 1,700 Stores Across 27 States MOCKSVILLE, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced major updates to its Pinnacle product manufacturing and marketing agreement with its top-5 c-store chain customer, including the launch of four new Pinnacle SKUs, including two in the low nicotine product category.
- 06/24/2025
|
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group
- New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.
- 05/21/2025
|
22nd Century to Present at the Emerging Growth Conference on May 21, 2025
- MOCKSVILLE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present a brief corporate update at the Emerging Growth Conference on Wednesday, May 21, 2025, at 12:00 pm Eastern Time.
- 05/19/2025
|
22nd Century Group, Inc. (XXII) Q1 2025 Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode.
- 05/13/2025
|
22nd Century Group Reports First Quarter 2025 Financial Results
- Sales Increase Approximately 50% Sequentially as 2025 Growth Strategy Drives New Sales Activity with Both Internal and External Brand Assets Across Multiple Categories
- 05/13/2025
|
22nd Century Group Completes Sale of Needle Rock Farms Assets
- Further Strengthens Balance Sheet Cash Position MOCKSVILLE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced closing of the sale of its Needle Rock Farms assets with net proceeds of approximately $770,000 after expenses.
- 05/08/2025
|
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction
- Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender.
- 05/07/2025
|
22nd Century Group to Announce First Quarter 2025 Results on May 13, 2025
- MOCKSVILLE, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, will host a webcast on Tuesday, May 13, 2025, at 8:00 AM ET to discuss its 2025 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
- 05/05/2025
|
22nd Century Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
- MOCKSVILLE, N.C., April 17, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) has released the following notice according to THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NEW YORK:
- 04/17/2025
|
Emerging Growth Research Releases Quarterly Update Report on 22nd Century Group (XXII)
- Sheridan, Wyoming--(Newsfile Corp. - April 10, 2025) - Emerging Growth Research is pleased to release its latest quarterly update on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q4 2024 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.
- 04/10/2025
|
22nd Century Revenue Growth from Continued Expansion of CMO Volume with New Filtered Cigar Agreements
- MOCKSVILLE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced execution of two new agreements from former customers to supply their filtered cigar products.
- 04/09/2025
|
22nd Century Group, Inc. (XXII) Q4 2024 Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's Fourth Quarter and Full Year 2024 Conference Call and Webcast. At this time, all participants are -- have been placed in a listen-only mode.
- 03/20/2025
|
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results
- Launches 2025 Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Announces First VLN ® Partner Brands with Smoker Friendly Ready for Shipment in Q2 2025, Additional Partner VLN ® Brands in Discussion MOCKSVILLE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the fourth quarter and year-ended December 31, 2024, and provided an update on recent business highlights.
- 03/20/2025
|
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025
- MOCKSVILLE, N.C., March 14, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, will host a webcast on Thursday, March 20, 2025, at 8:00 AM ET to discuss its 2024 fourth quarter and full year results, which are to be reported in a press release at 6:00 AM ET the same day.
- 03/14/2025
|
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly
- Smoker Friendly Adds Both VLN and Smoker Friendly Branded VLN Reduced Nicotine Content Products to its Store Lineup MOCKSVILLE, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced that it has signed an agreement with Smoker Friendly, one of its largest customers, to launch Smoker Friendly VLN branded reduced nicotine content cigarette products that will become the first VLN partner brand.
- 03/10/2025
|
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)
- Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed.
- 02/19/2025
|
22nd Century to Present at the Emerging Growth Conference on February 19, 2025
- MOCKSVILLE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present at the Emerging Growth Conference on Wednesday, February 19, 2025, at 10:50 am Eastern Time.
- 02/06/2025
|
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards
- MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2).
- 01/27/2025
|
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard
- New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
- 01/15/2025
|
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers
- VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA's War on Smoking
- 01/14/2025
|
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
- FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food and Drug Administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the U.S. Office of Management and Budget on January 3, 2025.
- 01/13/2025
|
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly
- Agreement covers 11 existing brands, supports launch 8 additional premium brands with Smoker Friendly retail and dealer locations
- 01/07/2025
|
22nd Century Announces 1-for-135 Reverse Stock Split
- Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
- 12/13/2024
|
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
- Recent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden Administration Mocksville, North Carolina--(Newsfile Corp. - December 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it applauds action by the U.S. Food and Drug Administration to advance its long-standing proposal mandating a drastic reduction in the amount of nicotine in cigarettes, a cornerstone goal of public health experts seeking to reduce the harms of smoking. "We are excited to see definitive action by the FDA intended to advance its scientifically backed reduced nicotine content mandate for cigarette products, a non-partisan proposal that actually began moving forward during the first Trump administration and continued its progress during the Biden administration," said Larry Firestone, Chief Executive Officer of 22nd Century Group.
- 12/12/2024
|
22nd Century Group Reports Third Quarter 2024 Financial Results
- Remains on Path to Cash Positive Operations in Q1 2025 Commencing Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Mocksville, North Carolina--(Newsfile Corp. - November 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the third quarter ended September 30, 2024, and provided an update on recent business highlights. Third Quarter 2024 Financial Results (compared to Second Quarter 2024, except as noted) All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis business in late 2023.
- 11/12/2024
|
22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024
- Mocksville, North Carolina--(Newsfile Corp. - November 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, will host a webcast on Wednesday, November 12, 2024, at 8:00 AM ET to discuss its 2024 third quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
- 11/07/2024
|
22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
- Mocksville, North Carolina--(Newsfile Corp. - October 21, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will be presenting at the LD Micro Main Event XVII investor conference to be held October 28-30, 2024 in Los Angeles. As part of the conference, the Company will conduct a group presentation at 3:30 pm Pacific Time on Wednesday, October 30, 2024.
- 10/21/2024
|
22nd Century Regains Compliance with Nasdaq Stockholders' Equity Requirement
- Mocksville, North Carolina--(Newsfile Corp. - October 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). This confirmation follows the Company's successful efforts to improve its balance sheet and liquidity by completing new equity offerings, while reducing outstanding liabilities and debt through various forms of settlement with creditors.
- 10/08/2024
|
22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
- CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability Mocksville, North Carolina--(Newsfile Corp. - September 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced a commitment from an existing customer to also supply their filtered cigar products. As part of this customer relationship, 22nd Century Group will assume production of all the customer's filtered cigar products using an in-house predicate blend.
- 09/25/2024
|
22nd Century Announces New Branded Products Order with Customer for Southeast Asia
- New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile Mocksville, North Carolina--(Newsfile Corp. - September 23, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced a new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. The first shipment is expected in the fourth quarter of 2024, with the opportunity to significantly expand volumes as the customer launches in key markets throughout 2025.
- 09/23/2024
|
22nd Century Updates Strategic Growth Initiatives for VLN
- Low nicotine tobacco stock on hand can supply up to $85.0 million worth of VLN® revenue and positive cash flow Plans announced for VLN® targeted distribution and expansion to reach over 270,000 retail outlets, expanded international activity, and flanker VLN® brands with existing CMO private label customers Mocksville, North Carolina--(Newsfile Corp. - September 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced plans to expand distribution of its VLN® 95% reduced nicotine content smoking products. Based on recent consumer point-of-sale data on VLN® sales, the Company is now moving to expand its sales and marketing operations to all available retail outlets in the US as well as growing its distributions worldwide.
- 09/11/2024
|
22nd Century Satisfies IP Licensing and Sponsored Research Obligations to NCSU Through 2025 in an Equity Transaction
- Mocksville, North Carolina--(Newsfile Corp. - September 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company leading the fight against nicotine addiction with its FDA authorized 95% less nicotine brand VLN®, today announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal valued at over $1.2 million. The payments will occur over the course of three tranches, in equity or cash, at the company's election.
- 09/09/2024
|
22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024
- Mocksville, North Carolina--(Newsfile Corp. - September 6, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company leading the fight against nicotine with its 95% less nicotine brand VLN® focused on nicotine harm reduction and contract manufacturing, today announced that it will participate in the HC Wainwright Conference on September 10, 2024 at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative.
- 09/06/2024
|
22nd Century Raises $1.68 Million in Regulation A Offering, Amends Senior Secured Credit Facility
- Mocksville, North Carolina--(Newsfile Corp. - August 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it has secured an additional $1.68 million in gross proceeds from institutional investors through its Regulation A offering priced at $0.57 and from a separate private placement of common warrants. The Company also entered into an amendment to its existing debentures held by JGB Partners and related entities ("JGB").
- 08/28/2024
|
22nd Century Group to Participate in the Emerging Growth Virtual Conference on August 21, 2024
- Mocksville, North Carolina--(Newsfile Corp. - August 20, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it will provide a brief corporate update as part of the Emerging Growth Virtual Conference on Wednesday, August 21, 2024 at 4:25 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.
- 08/20/2024
|
22nd Century Group Reports Second Quarter 2024 Financial Results
- Path to Cash Positive Operations in Q1 2025; Continued Fiscal Discipline with 2Q24 Financial Results; Reduced Net Debt by ~$6.3 Million Year-to-Date Mocksville, North Carolina--(Newsfile Corp. - August 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) today announced results for the second quarter ended June 30, 2024, and provided an update on recent business highlights. Second Quarter 2024 Financial Results (compared to First Quarter 2024, except as noted) All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis franchise in late 2023.
- 08/13/2024
|
22nd Century Group to Announce Second Quarter 2024 Results on August 13, 2024
- Mocksville, North Carolina--(Newsfile Corp. - August 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, will host a webcast on Tuesday, August 13, 2024, at 8:00 AM ET to discuss its 2024 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
- 08/06/2024
|
22nd Century Appoints Robert Manfredonia as Executive Vice President of Sales and Marketing
- Almost 30 years of experience in regulated consumer products sales Mocksville, North Carolina--(Newsfile Corp. - July 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced the appointment of Robert Manfredonia as Executive Vice President of Sales and Marketing, effective August 1, 2024. "I am excited to have Robert join 22nd Century as we round out the executive team.
- 07/30/2024
|
22nd Century Announces New Greenbutts Manufacturing Agreement for Innovative Plant-Based, Biodegradable Cigarette Filters
- Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced an agreement with Greenbutts, LLC to provide manufacturing space at its Mocksville, North Carolina NASCO manufacturing facility and NASCO staff to operate the manufacturing equipment for an innovative new cigarette filter solution. Greenbutts offers a patented technology to replace single-use, plastic-based filters currently used in tobacco products with water soluble, fully biodegradable filter solutions.
- 07/10/2024
|
22nd Century to Re-Launch and Expand VLN(R) Presence in South Korea
- Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine content cigarettes in South Korea. The new agreement with 22nd Century's local partner, Nico-Tech Korea, Inc., follows an initial test launch conducted in 2022 that identified product updates needed to align with local South Korean cigarette characteristics and appeal to the specific preferences of adult smokers in Korea.
- 07/09/2024
|
22nd Century Group to Participate in the Emerging Growth Virtual Conference on July 17, 2024
- Mocksville, North Carolina--(Newsfile Corp. - July 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it will present at the Emerging Growth Virtual Conference on Wednesday, July 17, 2024 at 11:25 AM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.
- 07/08/2024
|
22nd Century Reduces Debt by Additional $1.5 Million via Payment from GVB
- Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissory note. The amount was paid by GVB directly to the lender under terms of the note executed in conjunction with GVB's December 2023 purchase of 22nd Century Group's previous hemp/cannabis assets.
- 06/25/2024
|
22nd Century Announces Resignation of John Miller as President of Tobacco
- Helped Establish National Scale Distribution and Launch VLN in More Than 5,000 Stores Across the Country Mocksville, North Carolina--(Newsfile Corp. - May 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that John Miller has resigned as President of Tobacco, effective August 2, 2024. Said Larry Firestone, Chairman and CEO: "I want to thank John for the pivotal role he played in the launch of VLN®, leveraging his decades of industry experience to help us achieve national-scale distribution and establishing a retail presence in more than 5,000 stores across 26 states.
- 05/30/2024
|
22nd Century Group, Inc. (XXII) Q1 2024 Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2024 Earnings Conference Call May 15, 2024 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Daniel Otto - CFO Conference Call Participants Operator Welcome to the 22nd Century Group's First Quarter 2024 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode.
- 05/15/2024
|
22nd Century Group Reports First Quarter 2024 Financial Results
- New Contracts to Boost Second Quarter Revenue Reduced Operating Costs, Improved Cash Position Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024 Mocksville, North Carolina--(Newsfile Corp. - May 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the first quarter ended March 31, 2024, and provided an update on recent business highlights. First Quarter 2024 Financial Results All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of its hemp/cannabis franchise in late 2023.
- 05/15/2024
|
22nd Century Eliminates an Additional $2.3 Million of Debt
- Continues to Improve Balance Sheet and Move Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - May 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to eliminate an additional $2.3 million in outstanding debt with JGB Capital. Under the terms of the agreement, the Company and JGB Capital will exchange an aggregate of $2.3M in principal, fees and expenses owed to JGB Capital for consideration of approximately 1.375 million shares of the Company's common stock and pre-funded warrants.
- 05/13/2024
|
22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024
- Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Aegis Capital Virtual Conference on Thursday, May 9, 2024 at 2:30 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.
- 05/08/2024
|
22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024
- Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
- 05/07/2024
|
22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction
- Improves Balance Sheet, Eliminates Future Omnia Interest Expense and Increases Shareholder Equity Mocksville, North Carolina--(Newsfile Corp. - April 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to redeem $5.2 million in outstanding principal and interest associated with the Omnia subordinated note and outstanding warrants. The agreement will exchange consideration of approximately $248,000 in cash, 1.15 million shares of common stock priced at $2.14 per share, and 1.15 million shares of pre-funded warrants priced at $2.14 per share as consideration of the debt.
- 04/30/2024
|
22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors
- Intends to Reduce Board to Four Seats in Upcoming Proxy Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that Nora Sullivan and James Mish have resigned as a Directors, effective immediately. The Company does not intend to fill the vacated seats and will instead reduce the board to 4 seats as part of its focus on corporate cost efficiency.
- 04/18/2024
|
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule
- Continues Focus on Growing Sales with New Contracts, Progress Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing. Said Larry Firestone, Chairman and CEO: "We are pleased to regain compliance with the Nasdaq listing standards related to minimum bid price, another win in our efforts to improve our business step by step, every day, with steady progress on all fronts.
- 04/18/2024
|
22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024
- Mocksville, North Carolina--(Newsfile Corp. - April 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 3:30 PM Pacific Time. To access the live presentation, please use the following information:Date: Wednesday, May 1, 2024Time: 3:30 PM Pacific TimeWebcast: https://ir.xxiicentury.com/ Management will also host individual investor meetings on Thursday, May 2, 2024, as part of its participation in the conference.
- 04/15/2024
|
22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products
- Pinnacle Branded Products Growing At Over 10% at Top-5 U.S. C-Store Chain Mocksville, North Carolina--(Newsfile Corp. - April 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has expanded its Pinnacle private label brand to add distribution of cigarillo products to its existing Pinnacle cigarette products. Pinnacle products are currently sold as a private label brand in a top-5 U.S. gas station convenience store chain comprising approximately 1,700 stores in 26 states.
- 04/11/2024
|
22nd Century Announces Plan to Eliminate Its Senior Secured Debt
- Company Bolsters Balance Sheet with $4.2 Million Capital Infusion New Senior Leadership Team Announced to Further Drive Shareholder Value Mocksville, North Carolina--(Newsfile Corp. - April 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement with its senior secured lender, intended to eliminate all of its senior secured debt through potential debt for equity exchanges. Additionally, the Company has entered into separate definitive agreements for the purchase of common stock and warrants.
- 04/08/2024
|
Why Is 22nd Century (XXII) Stock Down 33% Today?
- 22nd Century (NASDAQ: XXII ) stock is falling on Monday as the tobacco products company is in danger of being delisted from the Nasdaq Exchange . The tobacco company was sent a delisting notice from the Nasdaq Listing Qualifications Department last week.
- 04/08/2024
|
Why Is 22nd Century Group (XXII) Stock Up 100% Today?
- Shares of tobacco specialist 22nd Century Group (NASDAQ: XXII ) are up today after the company announced a “significant” new contract manufacturing agreement. The deal centers on the production of branded conventional cigarette products.
- 04/05/2024
|
22nd Century Group (XXII) Signs Large New CMO Customer
- New Contract Will Commence in Second Quarter, Ultimately Boost CMO Volumes by More Than 20% Mocksville, North Carolina--(Newsfile Corp. - April 4, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has signed a significant new contract manufacturing agreement for the production of branded conventional cigarette products. The contract, which will commence revenue generation in the second quarter of 2024, is expected to increase carton production volumes at 22nd Century's manufacturing facility by more than 20 percent when fully implemented.
- 04/04/2024
|
22nd Century Group, Inc. (XXII) Q4 2023 Earnings Call Transcript
- 22nd Century Group, Inc. (XXII) Q4 2023 Earnings Call Transcript
- 03/28/2024
|
22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Results
- Mocksville, North Carolina--(Newsfile Corp. - March 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the fourth quarter ended December 31, 2023, and provided an update on recent business highlights. Fourth quarter results and recent business activities included: Net revenue from continuing operations in the fourth quarter of 2023 was $7.4 million, Exited hemp/cannabis operations to fully focus on tobacco harm reduction and contract manufacturing activities, Substantially reduced operating costs through efficiency initiatives and the hemp/cannabis business sale, Began new initiatives to increase sales, improve gross margin and increase operating profit in 2024, and Commenced developing new customer engagement strategies to drive additional sales growth in the FDA authorized VLN® products available in more than 5,100 stores across 26 states.
- 03/28/2024
|
22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024
- Mocksville, North Carolina--(Newsfile Corp. - March 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve smoker health and wellness, will host a live webcast on Thursday, March 28, 2024, at 8:00 AM ET to discuss its 2023 fourth quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Hugh Kinsman, chief financial officer, will review financial results and discuss progress made in the recent months.
- 03/15/2024
|
3 Tobacco Stocks Grabbing Attention on Solid Industry Trends
- The Zacks Tobacco industry companies have been benefiting from their pricing power and strength in smoke-free products amid an inflationary landscape. These upsides keep Philip Morris (PM), Altria Group (MO) and 22nd Century Group (XXII) well-placed.
- 02/23/2024
|
22nd Century Group Announces Reduction in Board Compensation
- Reduced Cost Structure Expected to Save more than $1Million Annually in 2024, Aligns Board with Corporate-Wide Lean Operating Commitment Mocksville, North Carolina--(Newsfile Corp. - February 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced a reduction in board compensation expenses expected to save more than $1 million in annual cost for 2024. In addition to the newly reduced cash compensation structure going forward, the board has also waived any cash compensation due to non-employee directors for the fourth quarter of 2023 and the first quarter of 2024 and voted to forgo any equity compensation grants for directors in 2024.
- 02/13/2024
|
22nd Century Group to Present at the Emerging Growth Conference on February 8, 2024
- Mocksville, North Carolina--(Newsfile Corp. - February 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company will present at the Emerging Growth Conference on February 8, 2024. Larry Firestone, Chairman and Chief Executive Officer, will present as part of an interactive Q&A session with the conference host at 10:50 am Eastern Time.
- 02/06/2024
|
22nd Century (XXII) Expands VLN Cigarettes to 1,200 Drug Stores
- 22nd Century Group's (XXII) VLN cigarettes represent a remarkable breakthrough as the first and only combustible cigarettes that the FDA has authorized as Modified Risk Tobacco Products.
- 09/13/2023
|
22nd Century (XXII) Begins Strategic Review of Tobacco Assets
- 22nd Century (XXII) is embarking on a strategic journey to unlock the full potential of its tobacco assets. This reflects the company's commitment to delivering long-term value to its shareholders.
- 09/06/2023
|
All You Need to Know About 22nd Century (XXII) Rating Upgrade to Buy
- 22nd Century (XXII) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 08/23/2023
|
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
- Penny stocks are often defined as stocks trading under $5 per share, those with a very low price per share or market capitalization, and are generally higher-risk. Now, despite many such stocks certainly carrying a relatively high risk profile, this often is somewhat offset by higher potential returns.
- 08/14/2023
|
22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023
- BUFFALO, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at a revised time of 8:00 AM ET to discuss its 2023 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
- 08/09/2023
|
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023
- BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
- 08/07/2023
|
Updates On 22nd Century Group As Its Stock Rises 87% Post Split
- 22nd Century Group's stock price increased by 87% last week, following a 1:15 reverse split in early July; the company's valuation has improved since the split. The company has seen rapid growth following FDA approval of its very low nicotine (VLN) cigarettes and its acquisition of GVB BioPharma. Because of recent volatility, I rate the company as a hold; one should wait for price stabilization before making a long-term investment.
- 07/24/2023
|
22nd Century Group (XXII) Boosts VLN Offerings in Montana
- 22nd Century Group (XXII) expands its VLN offerings in Montana by adding Town Pump convenience stores to its product distribution channel.
- 07/17/2023
|
3 Doomed Stock-Split Stocks Destined for Disaster
- Stock Split is a regular occurrence within the stock market. However, they are much more common among stocks at risk of being delisted from an exchange such as NASDAQ due to minimum bid requirements that revolve around a company's share price.
- 07/14/2023
|
Best Penny Stocks To Buy Now? 3 To Watch Right Now
- Ever heard of penny stocks? If you're new to investing, you might be scratching your head.
- 07/07/2023
|
Watch These 3 Tobacco Stocks on Favorable Industry Trends
- The Zacks Tobacco industry players gain from their pricing power and focus on smoke-free products amid cost inflation and low cigarette volumes. Philip Morris (PM), Altria Group (MO) and 22nd Century Group (XXII) look well-placed.
- 06/21/2023
|
22nd Century Group (XXII) Reports Q1 Loss, Tops Revenue Estimates
- 22nd Century Group (XXII) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago.
- 05/09/2023
|
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
- BUFFALO, N.Y., May 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Tuesday, May 9, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
- 05/03/2023
|
22nd Century Group, Inc. (XXII) Q4 2022 Earnings Call Transcript
- 22nd Century Group, Inc. (XXII) Q4 2022 Earnings Conference Call March 9, 2023 10:00 AM ET Corporate Participants Matt Kreps - Investor Relations Jim Mish - Chief Executive Officer John Miller - President, Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Vivien Azer - TD Cowen Alex Fuhrman - Craig-Hallum Capital Group Brian Wright - ROTH MKM Jim McIlree - Dawson James Operator Good day, ladies and gentlemen, and welcome to the 22nd Century Group's Fourth Quarter and Year-End Results Conference Call. At this time all lines are in a listen-only mode.
- 03/09/2023
|
22nd Century Group (XXII) Reports Q4 Loss, Lags Revenue Estimates
- 22nd Century (XXII) delivered earnings and revenue surprises of -100% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 03/09/2023
|
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
- BUFFALO, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that the Company will be participating in one-on-one meetings during the 35th Annual Roth Conference, to be held March 12-14, 2023 in Orange County, California.
- 03/02/2023
|
3 Best Marijuana Stocks to Buy in December
- All three are pursuing strategies that are working and will work even better in the long term.
- 12/01/2022
|
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
- BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company will be participating in the following investor conferences:
- 11/14/2022
|
22nd Century Group, Inc. (XXII) Q3 2022 Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q3 2022 Earnings Conference Call November 8, 2022 10:00 AM ET Company Participants Mei Kuo - Director of Communications and Investor Relations James Mish - Chief Executive Officer John Miller - President, Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Vivien Azer - Cowen & Company Aaron Grey - Alliance Global Partners Brian Wright - Roth Capital Partners Jim McIlree - Dawson James Alex Fuhrman - Craig Hallum Operator Welcome to the 22nd Century Group's Third Quarter 2022 Conference Call and Webcast. At this time all participants' have been placed in a listen-only mode and the floor will be opened for your questions following management's prepared remarks.
- 11/08/2022
|
22nd Century Group (XXII) Reports Q3 Loss, Lags Revenue Estimates
- 22nd Century (XXII) delivered earnings and revenue surprises of -20% and 1.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/08/2022
|
22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022
- BUFFALO, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will release third quarter 2022 financial results on Tuesday, November 8, 2022, at 6:00 a.m. ET. In conjunction with the news release, 22nd Century Group will host a conference call at 10:00 a.m. ET on the same day.
- 10/27/2022
|
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
- BUFFALO, N.Y., Oct. 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that James A. Mish, chief executive officer, will present at the LD Micro Main Event Investor Conference in Los Angeles, California on Wednesday, October 26, 2022 at 11:00 a.m. PT.
- 10/18/2022
|
Best Penny Stocks To Buy Now That CPI Is Out? 5 For Your Watch List
- Best penny stocks to buy right now? The post Best Penny Stocks To Buy Now That CPI Is Out?
- 10/13/2022
|
22nd Century Group, Inc. (XXII) CEO Jim Mish on Q2 2022 Results - Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q2 2022 Earnings Conference Call August 9, 2022 10:00 AM ET Company Participants Joe Schepers - Vice President of Communications & Investor Relations Jim Mish - Chief Executive Officer John Miller - President of Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Vivien Azer - Cowen Aaron Grey - Alliance Global Partners Brian Wright - Roth Capital Partners Jim McIlree - Dawson James Alex Berman - Craig-Hallum Capital Group Operator Welcome to the 22nd Century Group's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode and the floor will be opened for questions following management's prepared remarks.
- 08/09/2022
|
22nd Century Group (XXII) Reports Q2 Loss, Tops Revenue Estimates
- 22nd Century (XXII) delivered earnings and revenue surprises of -20% and 18.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/09/2022
|
22nd Century (XXII) Upgraded to Strong Buy: Here's What You Should Know
- 22nd Century (XXII) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 08/04/2022
|
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022
- BUFFALO, N.Y., July 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will host a live webcast on Tuesday, August 9, 2022, at 10:00 AM ET to discuss its 2022 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
- 07/27/2022
|
Everyone Says Sell Your Cannabis Stocks! I See It Differently (Podcast Transcript)
- Alan Sumler discusses his long cannabis positions and investing through a medical and historical lens. A rare opinion - Positive on Canada!
- 07/26/2022
|
22nd Century Group's Road to Cannabis May Have Some Potholes
- The biotechnology company is working hard to get up to speed, but it risks running out of highway.
- 07/26/2022
|
Everyone Says Sell Your Cannabis Stocks! I See It Differently
- Alan Sumler comes from the world of academia and brings that perspective to cannabis investing. Long positions and how he approaches his stock analysis.
- 07/13/2022
|
This Under-the-Radar Stock Just Got a Huge Gift From the Biden Administration
- It'll benefit from proposed rules that may eventually limit nicotine in cigarettes.
- 07/08/2022
|
This Little-Known Tobacco Stock Is Getting a Huge Boost
- The FDA's plan to reduce nicotine in cigarettes to near zero could mean big sales for this stock.
- 06/26/2022
|
Two Tobacco Stocks That Would Be Affected By FDA Limits On Nicotine In Cigarettes
- The Food and Drug Administration (FDA) had planned to place a limit on nicotine levels in cigarettes and related products in 2009.
- 06/25/2022
|
If Biden Nixes Nicotine, 22nd Century Group Stock Could 10X
- Slashing the amount of nicotine allowed in cigarettes will disrupt the entire cigarette industry in its favor.
- 06/25/2022
|
Why 22nd Century Group Stock Soared Today
- The Biden administration proposed a new limit on the amount of nicotine allowed in cigarettes.
- 06/22/2022
|
22nd Century Group: Record Revenues On VLN Cigarettes And Cannabis IP
- 22nd Century Group reported $9 million in revenues for Q1-2022, up 33% YoY. The company has released its VLN cigarettes in America (Chicago) and South Korea.
- 05/09/2022
|
10 Marijuana Stocks Lighting Up With a Focus on Earnings
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.
- 05/06/2022
|
22nd Century Group's (XXII) CEO Jim Mish on Q1 2022 Results - Earnings Call Transcript
- 22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2022 Earnings Conference Call May 5, 2022 10:00 AM ET Company Participants Mei Kuo – Director of Communications and Investor Relations Jim Mish – Chief Executive Officer Mike Zercher – President and Chief Operating Officer Rich Fitzgerald – Chief Financial Officer Conference Call Participants Harrison Vivas – Cowen Brian Wright – Roth Capital Partners Jim McIlree – Dawson James Operator Welcome to the 22nd Century Group's First Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode and the floor will be opened for questions following management's prepared remarks, As a reminder, today's conference is being recorded.
- 05/05/2022
|
22nd Century Group (XXII) Reports Q1 Loss, Tops Revenue Estimates
- 22nd Century (XXII) delivered earnings and revenue surprises of 16.67% and 8%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
- BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on Thursday, May 5, 2022, at 10:00 AM ET to discuss its 2022 first quarter results. 22nd Century will report the Company's first quarter 2022 results in a press release at 6:00 AM ET the same day.
- 04/14/2022
|
22nd Century Group (XXII) CEO Jim Mish on Q4 2021 Results - Earnings Call Transcript
- 22nd Century Group (XXII) CEO Jim Mish on Q4 2021 Results - Earnings Call Transcript
- 03/01/2022
|
22nd Century Group (XXII) Reports Q4 Loss, Lags Revenue Estimates
- 22nd Century (XXII) delivered earnings and revenue surprises of -20% and 9.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2022
|
11 Marijuana Stocks on Fire to Close February
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
- 02/28/2022
|
3 Tobacco Stocks to Watch Despite Industry Headwinds
- The Zacks Tobacco industry players are battling stern government norms and pandemic-led woes like soft duty-free sales. That said, focus on low-risk products bode well for Philip Morris (PM), Altria (MO) and 22nd Century Group (XXII).
- 02/21/2022
|
4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
- 4 penny stocks with high short interest. The post 4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 02/14/2022
|
4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
- Are these short squeeze penny stocks on our watch list right now? The post 4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 02/11/2022
|
These Pot Stocks Went Wild This Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.
- 02/04/2022
|
22nd Century Group To Host Q4 & FY 2021 Earnings Call
- 22nd Century Group, Inc. XXII announced that it will host a live webcast on Tuesday, March 1, 2022, at 10:00 AM ET to discuss its 2021 fourth quarter and full year results. The company will report its fourth quarter and full year 2021 results in a press release at 6:00 AM ET the same day.
- 02/03/2022
|
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
- BUFFALO, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on Tuesday, March 1, 2022, at 10:00 AM ET to discuss its 2021 fourth quarter and full year results. 22nd Century will report the Company's fourth quarter and full year 2021 results in a press release at 6:00 AM ET the same day.
- 02/03/2022
|
Why 22nd Century Group Was on Fire in December With a 23% Gain
- The low-nicotine cigarette maker received the spark it was looking for to jump-start growth.
- 01/08/2022
|
22nd Century Group Stock (XXII): Why The Price Surged
- The stock price of 22nd Century Group Inc (NASDAQ: XXII) increased by 38.6% in the previous trading session. This is why it happened.
- 12/24/2021
|
Why 22nd Century Group Stock Skyrocketed Today
- The biotech wants to help smokers quit.
- 12/23/2021
|
22nd Century Group Rallies 55% Over FDA Approval To Market Its VLN Cigarettes In The U.S.
- 22nd Century Group Rallies 55% Over FDA Approval To Market Its VLN Cigarettes In The U.S.
- 12/23/2021
|
XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today?
- Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today.
- 12/23/2021
|
22nd Century Group, Aurora Cannabis And Cronos Group Set Sights On Cannabinoid Biosynthesis
- 22nd Century and Aurora Cannabis made an agreement with Cronos Group to license their cannabinoid biosynthesis intellectual property.
- 12/20/2021
|
Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos
- Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) together with 22nd Century Group, Inc. (NASDAQ:XXII) will license biosynthesis intellectual property to Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON). The licensed intellectual property is designed to help advance the research and development of the biosynthesis of cannabinoids.
- 12/15/2021
|
New Kid In Town — Cannabis Daily December 9, 2021
- Valens Co. Commences Trading on NASDAQ under symbol $VLNS Public companies discussed in today's episode:
- 12/09/2021
|
22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021
- BUFFALO, N.Y., Nov. 11, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, today announced that the Company will participate in the following virtual investor conferences during the month of November 2021:
- 11/11/2021
|
22nd Century Group's (XXII) CEO Jim Mish on Q3 2021 Results - Earnings Call Transcript
- 22nd Century Group's (XXII) CEO Jim Mish on Q3 2021 Results - Earnings Call Transcript
- 11/04/2021
|
22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines
- Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:XXII) reported its results on Thursday for the third quarter ended September 30, revealing net sales of $7.8 million for the period, up 6.9% from the prior year's period. Moreover, its year-to-date net sales totaled $23 million, up 11% from the corresponding period of last year.
- 11/04/2021
|
22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
- BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science, will host a live webcast on Thursday, November 4, 2021, at 10:00 AM ET to discuss its 2021 third quarter results. 22nd Century will report the Company's third quarter 2021 results in a press release at 6:00 AM ET the same day.
- 10/20/2021
|
Implied Volatility Surging for 22nd Century (XXII) Stock Options
- Investors need to pay close attention to 22nd Century (XXII) stock based on the movements in the options market lately.
- 10/04/2021
|
22nd Century to Participate in September and October 2021 Investor Conferences
- BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the following virtual investor conferences during the months of September and October 2021:
- 09/27/2021
|
What Happened with These 7 Marijuana Stocks This Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.
- 09/03/2021
|
22nd Century: Third Plant-Based Franchise And Record Q2 Revenues
- 22nd Century: Third Plant-Based Franchise And Record Q2 Revenues
- 09/01/2021
|
Why 22nd Century Group Shares Are Trading Lower Today
- 22nd Century Group Inc (NASDAQ: XXII) is trading lower Monday as investors react to the company's announcement it will enter the specialty hops market. The global specialty hops market will be 22nd Century Group's third and newest plant franchise.
- 08/30/2021
|
22nd Century Group Enters Global Specialty Hops Market
- Geographic Expansion into Europe via the Netherlands Geographic Expansion into Europe via the Netherlands
- 08/30/2021
|
22nd Century Group Announces Franchise In Global Specialty Hops Market
- 22nd Century Group Inc (NASDAQ:XXII) announced its entry Monday into the global speciality hops market. What Happened: 22nd Century Group is a leading plant biotechnology and intellectual property company focused on improving health and wellness through plant science.
- 08/30/2021
|
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
- Visionary in the Fields of Biotechnology and Genomics to Extend Broad Expertise to Company's Strategy, Technology Development, Commercialization, and Value Creation Efforts
- 08/19/2021
|
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
- Analysts say these are penny stocks to buy. Do you agree?
- 08/18/2021
|
22nd Century to Present at SNN Network Investor Conference on August 19
- BUFFALO, N.Y., Aug. 17, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that its Chief Executive Officer, James A. Mish, is scheduled to present at the SNN Network Summer Virtual Event investor conference on Thursday, August 19, 2021 at 2:30 p.m. ET.
- 08/17/2021
|
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
- BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it will ring the Nasdaq Closing Bell today, August 16, 2021, in celebration of the transfer of its stock listing to the Nasdaq Capital Market from the NYSE American. The company's common stock begins trading today at the market open under the same ticker symbol “XXII.”
- 08/16/2021
|
3 Under-the-Radar Cannabis Stocks Investors Need to Know
- Only focusing on the industry's headliners means you'll miss out on some great opportunities.
- 08/07/2021
|
22nd Century Group to Begin Trading on Nasdaq on August 16, 2021
- BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq Capital Market effective as of the market open on August 16, 2021. The shares will continue to trade under the ticker symbol “XXII.”
- 08/05/2021
|
22nd Century Group, Inc. (XXII) CEO Jim Mish on Q2 2021 Results - Earnings Call Transcript
- 22nd Century Group, Inc. (XXII) CEO Jim Mish on Q2 2021 Results - Earnings Call Transcript
- 08/05/2021
|
22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch
- Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in Preparation for Projected Demand Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in Preparation for Projected Demand
- 07/22/2021
|
22nd Century Group to Host Webcast to Provide Business Update and Discuss Second Quarter 2021 Results
- BUFFALO, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, will host a live webcast on Thursday, August 5, 2021, at 10:00 AM ET to discuss its 2021 second quarter results. 22nd Century will report the Company's second quarter 2021 results in a press release at 6:00 AM ET the same day.
- 07/19/2021
|
Smoking Hot Cannabis Stocks Making Moves Right Now
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.
- 07/16/2021
|
22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture and Folium Botanical for Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up
- BUFFALO, N.Y., July 14, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has added strategic partnerships with expert commercial-scale plant breeders Sawatch Agriculture and Folium Botanical. The partnerships with these two northern hemisphere breeders add to the breeding capabilities that 22nd Century already has through its close partnership with Aurora Cannabis, and another southern hemisphere-based breeder that will be announced shortly, providing 22nd Century year-round growing capabilities.
- 07/14/2021
|
7 Reddit Penny Stocks for Your July Buy List
- Reddit's retail crowd may buy these seven penny stocks whose sound business fundamentals and relative under-valuation will close the gap for tremendous upside. The post 7 Reddit Penny Stocks for Your July Buy List appeared first on InvestorPlace.
- 07/07/2021
|
Pot Stock Roundup: Apple Enters the Fray
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry continues to shape up in 2021.
- 07/02/2021
|
22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities
- 22nd Century Takes Ownership of Needle Rock Farms, Provides North American Cultivation Base of Operations 22nd Century Takes Ownership of Needle Rock Farms, Provides North American Cultivation Base of Operations
- 07/01/2021
|
22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives
- BUFFALO, N.Y., June 25, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today released an update letter to its shareholders from CEO James A. Mish.
- 06/25/2021
|
7 A-Rated Biotech Stocks to Buy Now
- Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios. The post 7 A-Rated Biotech Stocks to Buy Now appeared first on InvestorPlace.
- 06/15/2021
|
Smoked! How the Hottest Cannabis Stocks Fared This Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.
- 06/11/2021
|
22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering
- Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises. Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises.
- 06/09/2021
|
Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes
- BUFFALO, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, is pleased to announce that it will be added to the Russell 2000®, Russell 3000®, and Russell Global Indexes at the conclusion of the Russell US Indexes annual reconstitution, effective at the opening of the U.S. equity markets on June 28, 2021.
- 06/09/2021
|
Why 22nd Century Group, HEXO, and Canopy Growth Stocks All Popped Today
- Two cannabis companies team up to explore new forms of cannabis consumption.
- 06/07/2021
|
Shares of 22nd Century Group's Cannabis Research Co. Slightly Up On $40M Registered Direct Offering With Cowen and Company
- Plant-based biotech company 22nd Century Group, Inc. (NYSE AMEX: XXII) announced Monday it will raise $40 million via a registered direct offering with one institutional investor. The Buffalo, New York-based company involved in cannabis and hemp research agreed to sell 10 million common shares with a price of $4.00 per share.
- 06/07/2021
|
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
- BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced new initiatives to strengthen and maximize revenue opportunities in its hemp/cannabis franchise. Included in these developments is the announcement of strategic partnerships with two plant breeders in the northern and southern hemispheres providing the Company with year-round growing capabilities, close partnership activities being conducted with Aurora Cannabis, and the establishment of a newly created Canadian subsidiary. These newest developments further support 22nd Century's plans for multiple avenues of hemp/cannabis revenue that will begin to be realized in late 2021.
- 06/07/2021
|
22nd Century Announces $40 Million Common Stock Registered Direct Offering
- Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises. Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises.
- 06/07/2021
|
22nd Century to Participate in May and June 2021 Investor Conferences
- BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021:
- 05/24/2021
|
Best Penny Stocks to Invest in 2021? Here's 3 To Check Out
- Top penny stocks in 2021? Check these 3 out for some watchlist inspiration The post Best Penny Stocks to Invest in 2021?
- 05/19/2021
|
8 Reddit Penny Stocks That May Withstand the Market Maelstrom
- Looming uncertainty may be bad news for most Reddit penny stocks, but these eight may hold onto their gains, or head higher, from here. The post 8 Reddit Penny Stocks That May Withstand the Market Maelstrom appeared first on InvestorPlace.
- 05/18/2021
|
22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference
- Research Shows Cigarette Addiction Disproportionately Harms Minority and Vulnerable Communities; Mandating Reduced Nicotine Content in Cigarettes Would Help Counteract Years of Targeted Marketing of Addictive and Deadly Products by Big Tobacco Research Shows Cigarette Addiction Disproportionately Harms Minority and Vulnerable Communities; Mandating Reduced Nicotine Content in Cigarettes Would Help Counteract Years of Targeted Marketing of Addictive and Deadly Products by Big Tobacco
- 05/18/2021
|
5 Hot Penny Stocks To Buy? Check These Out For May 2021
- Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?
- 05/10/2021
|
What Happened with Marijuana Stocks This Week?
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.
- 05/07/2021
|
Hot Penny Stocks To Buy This Week? 3 That Could Make Your Watchlist
- Are these the hottest penny stocks to watch this week? That's for you to decide The post Hot Penny Stocks To Buy This Week?
- 05/06/2021
|
22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
- Updated Agreement Extends Exclusive Program to Create Valuable, New Hemp/Cannabis Varieties and Expands Collaboration to Include 22nd Century's Two Other Plant Franchises
- 05/04/2021
|
These 10 Pot Stocks Smoked the Last Week of April
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.
- 04/30/2021
|
22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
- Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation and Reduced Disparities; Movement on Nicotine Cap by FDA Expected to be Forthcoming
- 04/30/2021
|
An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring
- The same old story could have a different ending this time for investors.
- 04/30/2021
|
5 Reddit Penny Stocks Seeing the Most Chatter Thursday
- Investors can seem to get enough of Reddit penny stocks news and we're looking at the most talked-about ones for Thursday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared first on InvestorPlace.
- 04/29/2021
|
Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities
- When Mandate is Implemented, 22nd Century is Fully Prepared to Deliver VLN® Reduced Nicotine Content Cigarette, the Only Combustible Product in Line with FDA's Proposed Nicotine Cap When Mandate is Implemented, 22nd Century is Fully Prepared to Deliver VLN® Reduced Nicotine Content Cigarette, the Only Combustible Product in Line with FDA's Proposed Nicotine Cap
- 04/29/2021
|
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
- To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for Numerous Independent Scientific Studies
- 04/26/2021
|
4/20 Holiday Week Had These Cannabis Stocks Fired Up
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.
- 04/23/2021
|
22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results
- BUFFALO, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco and hemp/cannabis research, will host a live audio webcast on Thursday, May 6, 2021, at 10:00 AM ET to discuss its 2021 first quarter results. 22nd Century will report the Company's first quarter 2021 results in a press release at 6:00 AM ET the same day.
- 04/22/2021
|
22nd Century Group Issues Annual Letter to Shareholders
- Company's Confidence in MRTP Authorization is High; Launch of VLN® is Only the Beginning for Tobacco Franchise
- 04/21/2021
|
4 Trending Penny Stocks to Watch on Monday, April 19th
- Finding trending penny stocks can be a great place to start making a watchlist; here's 3 to consider The post 4 Trending Penny Stocks to Watch on Monday, April 19th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 04/19/2021
|
5 Red-Hot Pot Stocks That Made Headlines This Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry will continue to develop in the 2021.
- 04/16/2021
|
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
- New Zealand Ministry of Health Proposal Calls for Reducing Nicotine Content in Cigarettes to “Minimal Levels” to Help Smokers Quit, Prevent Addiction New Zealand Ministry of Health Proposal Calls for Reducing Nicotine Content in Cigarettes to “Minimal Levels” to Help Smokers Quit, Prevent Addiction
- 04/15/2021
|
Cannabis Movers & Shakers: JMP Group, GTI, Curaleaf, Conception Nurseries, Myconic, AMP, Neon, NCR, 22nd Century, cbdMD
- JMP Group Appoints Investment Expert Alfredo Barreto To Oversee Its Investment Banking Division JMP Group LLC (NYSE:JMP) said Tuesday that Alfredo Barreto, Jr. has joined the company to serve as a managing director in its investment banking group.
- 04/09/2021
|
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
- Another key indicator and milestone of the Increasing Importance of Reducing Cigarette Nicotine Content as Cornerstone of Public Health Policy Another key indicator and milestone of the Increasing Importance of Reducing Cigarette Nicotine Content as Cornerstone of Public Health Policy
- 04/08/2021
|
3 Best Emerging Marijuana Stocks to Buy in April
- Want to bet on rising stars in the $61 billion U.S. marijuana industry? Here are the top picks.
- 04/06/2021
|
Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century
- WILLIAMSVILLE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it continues to be confident on the renewal of the FDA's proposed reduced nicotine mandate that would make all cigarettes “minimally or non-addictive.” By way of support, four former U.S. Food and Drug Administration (FDA) commissioners, Robert M. Califf, M.D. MACC; Scott Gottlieb, M.D.; Peggy Hamburg, M.D.; and, Jane Henney, M.D., spoke on a recent panel and were vocal in their endorsement of the mandate to limit the amount of nicotine in cigarettes to levels already achieved by 22nd Century's reduced nicotine content cigarettes, VLN® .
- 04/01/2021
|
NY Inches Toward Legalization, Plus 4 Pot Stocks are Blazing
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.
- 03/26/2021
|
22nd Century Group Positioned For Growth In Cannabis And Tobacco Markets
- XXII is awaiting MRTP authorization from the FDA and, once granted, the company will bring to market its VLN cigarettes. The company is also positioned, via its partnerships, to introduce its high THC cannabis genetics to the market.
- 03/24/2021
|
22nd Century Group: Why We Use Options For Upcoming, Game-Changing MRTP Binary Event
- Management seems confident of MRTP approval. The VLN cigarette has no real competition in the combustible space.
- 03/22/2021
|
Becerra Confirmation Boosts 22nd Century's Position to Disrupt Tobacco Industry
- Confirmation of Becerra as New HHS Secretary May Reignite FDA's Plan to Eliminate Addictive Cigarettes Confirmation of Becerra as New HHS Secretary May Reignite FDA's Plan to Eliminate Addictive Cigarettes
- 03/19/2021
|
Do Options Traders Know Something About 22nd Century (XXII) Stock We Don't?
- Investors need to pay close attention to 22nd Century (XXII) stock based on the movements in the options market lately.
- 03/19/2021
|
Why 22nd Century Group Stock Just Lit Up
- Tobacco and marijuana bioengineering? Yeah, that's apparently a thing now.
- 03/12/2021
|
22nd Century Group's (XXII) CEO Jim Mish on Q4 2020 Results - Earnings Call Transcript
- 22nd Century Group's (XXII) CEO Jim Mish on Q4 2020 Results - Earnings Call Transcript
- 03/11/2021
|
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
- Key Business and Financial Highlights
- 03/11/2021
|
4 Cannabis Stocks in the News This Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.
- 03/05/2021
|
22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
- Breakthrough expected to yield disruptive plant lines and new licensing opportunities with strategic partners Breakthrough expected to yield disruptive plant lines and new licensing opportunities with strategic partners
- 02/10/2021
|
8 Pot Stocks in Focus Amid the WallStreetBets Frenzy
- Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will develop in the 2021.
- 02/01/2021
|
Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group
- WILLIAMSVILLE, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today the dismissal with prejudice of the federal securities class action lawsuit captioned Noto. V. 22nd Century Group, Inc., 19-CV-1285 by a federal district court in the Western District of New York on January 14, 2021. The case was initially filed in the Eastern District of New York, where it was captioned Bull v. 22nd Century Group, Inc. 1:19-CV-00409. In denying the Plaintiffs' request for an opportunity to file another amended Complaint, the Court held that “further amendment would be futile.”
- 01/19/2021
|
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company's Reduced Nicotine Content Cigarettes
- Company will significantly increase planting in the 2021 crop year Company will significantly increase planting in the 2021 crop year
- 01/12/2021
|
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company's Reduced Nicotine Content Cigarettes
- Company will significantly increase planting in the 2021 crop year Company will significantly increase planting in the 2021 crop year
- 01/11/2021
|
Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock?
- Investors need to pay close attention to 22nd Century (XXII) stock based on the movements in the options market lately.
- 12/15/2020
|
22nd Century Looks Set To Finally Cash In
- There are reasons to believe that the company will receive MRTP status, which enables the company to be the only company to sell and market VLN cigarettes. While investors have already piled in, MRTP status is a company-changing event, and the odds look pretty good.
- 12/10/2020
|
22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
- The Company's Research Cigarettes Continue to Fuel Studies Adding to the Vast Body of Research Supporting a National Nicotine Standard for Combustible Cigarettes The Company's Research Cigarettes Continue to Fuel Studies Adding to the Vast Body of Research Supporting a National Nicotine Standard for Combustible Cigarettes
- 12/08/2020
|
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
- WILLIAMSVILLE, N.Y., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that Chief Executive Officer, James A. Mish, will speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 11:50 a.m. EST. The virtual conference is a forum for objective first-hand updates on both marketed and emerging products across the spectrum of the cannabis industry focusing on consumer, technology, and healthcare.
- 11/18/2020
|
9 Cannabis Stocks Making Moves During an Explosive U.S. Election Week
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in the upcoming week.
- 11/06/2020
|
22nd Century Group, Inc. (XXII) CEO James Mish on Q3 2020 Results - Earnings Call Transcript
- 22nd Century Group, Inc. (XXII) CEO James Mish on Q3 2020 Results - Earnings Call Transcript
- 11/05/2020
|
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
- Key Highlights:
- 11/05/2020
|
